Gibthai Company LIMITED
Krung Thep Maha Nakhon
- UEI
- RC7VWH2MZKV3
- CAGE
- SZB01
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Tax Exempt)
- SAM.gov registration date
- Physical address
- 44/6 Soi Kanchana, Khwaeng Samsen Nok, Khet Huai Khwang, Krung Thep Maha Nakhon 10310, Thailand
- Website
- gibthai.com
- Founded
- 1985
- Employees
- 51-250
- Estimated annual revenue
- $10M-$50M
- Industry
-
- Health Care
- Health Care Equipment & Services
- Health Care Providers & Services
- Health Care Services
- SIC code
- 50 Wholesale Trade – Durable Goods
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Contract obligations by fiscal year
| Fiscal year | Obligated |
|---|---|
| FY2027 To date | $0 |
| FY2026 | $96,823 |
| FY2025 | $291,854 |
| FY2024 | $160,193 |
| FY2023 | $670,230 |
Top agencies by obligations
| Rank | Agency | Obligated, FY2026–FY2027 | Share |
|---|---|---|---|
| 1 | Department of the Army | $96,823 |
Contract awards
Latest 5 listed here. See the rest on GovTribe.
Similar vendors
| Vendor | Location | Primary NAICS |
|---|---|---|
| Bio-Active Company LIMITED | Krung Thep Maha Nakhon | 423490 Other Professional Equipment and Supplies Merchant Wholesalers |
| Zuellig Pharma LTD | — | 334516 Analytical Laboratory Instrument Manufacturing |
| Geneplus Company LIMITED | Krung Thep Maha Nakhon | 541714 Research and Development in Biotechnology (except Nanobiotechnology) |
| Dksh Technology LIMITED | Krung Thep Maha Nakhon | 621511 Medical Laboratories |
| Bio-Rad Laboratories LIMITED | Krung Thep Maha Nakhon | 334516 Analytical Laboratory Instrument Manufacturing |
About the company
Gibthai Company LIMITED (Gibthai Division), a for-profit entity headquartered in Thailand, supplies laboratory reagents, medical equipment, and diagnostic test kits to U.S. federal agencies as a prime contractor, competing exclusively in full-and-open procurements with no set-aside designations. The vendor operates as a single-award BPA holder and purchase-order prime for the Department of Defense's medical research and infectious disease testing programs, predominantly supporting work in Thailand and Southeast Asia.
Gibthai's customer concentration reflects a medical research footprint anchored in defense agencies. The Defense Health Agency dominates by potential value (13 awards, $8.9 million combined potential value), while the Department of the Army Medical Command leads by award count (40 awards, $1.2 million combined potential value). Together these two entities account for 95% of recent awards. The Department of State Bureau of East Asian and Pacific Affairs, the Department of Defense, and the Department of the Navy round out the active set with smaller individual award values. Gibthai holds a single-award Defense Health Agency BPA (W81XWH19A0014) valued at $1,216,000 through September 2029, from which two calls have issued since March 2025: a $44,581 call for RT-PCR assay reagents to detect influenza, dengue, Zika, chikungunya, and SARS-CoV-2 viruses on ABI PRISM systems, and an $11,000.25 call for reagents and medical supplies with performance in Washington, DC.
Gibthai's capability portfolio centers on importation and distribution of Invitrogen and Gibco branded laboratory reagents, real-time PCR systems (QuantStudio 7 Pro and ABI PRISM equipment), biological safety cabinets, microscopes, and diagnostic test kits for infectious disease detection and characterization. Recent named work includes a $96,823 September 2026 Army purchase order for a QuantStudio 7 Pro real-time PCR system in Thailand, a $181,658 Army purchase order from July 2023 for a real-time PCR system supporting the Armed Forces Research Institute of Medical Sciences (AFRIMS), a $20,784 Army acquisition of biological safety cabinets for AFRIMS in August 2023, and a $123,839 Defense Health Agency acquisition of a QuantStudio 7 Pro for AFRIMS in September 2025. Activity spiked in 2023 (ten awards) with lower volume in 2024, 2025, and 2026 combined. Only one award faces ultimate completion in the next twenty-four months ($97 thousand potential value), presenting minimal recompete near-term exposure. Gibthai operates solely as a prime contractor (100% of awards); the vendor carries no subcontract footprint in the source data.
Quick answers
Is Gibthai Company LIMITED registered in SAM.gov?
Yes. Gibthai Company LIMITED's SAM.gov registration is active through March 25, 2027.
How much has Gibthai Company LIMITED received in federal contracts?
Federal contracts obligated $291,854 to Gibthai Company LIMITED in fiscal year 2025 and $1,219,100 in fiscal years 2023 through 2027.
What is Gibthai Company LIMITED's most recent federal award?
Gibthai Company LIMITED's most recent federal contract award is Supply and delivery of quantstudio 7 pro real-time PCR system and related equipment and accessories (19GE5026P0095), from Office of Acquisition Management, on September 17, 2026.
On GovTribe
See Gibthai Company LIMITED's full federal record
- Federal contract awards
- IDV awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors